PortfoliosLab logoPortfoliosLab logo
EAT vs. SMMT
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

EAT vs. SMMT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Brinker International, Inc. (EAT) and Summit Therapeutics Inc. (SMMT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, EAT achieves a 1.83% return, which is significantly higher than SMMT's -19.33% return. Over the past 10 years, EAT has outperformed SMMT with an annualized return of 13.68%, while SMMT has yielded a comparatively lower 4.15% annualized return.


EAT

1D
4.04%
1M
5.38%
YTD
1.83%
6M
2.69%
1Y
-14.86%
3Y*
59.52%
5Y*
18.17%
10Y*
13.68%

SMMT

1D
-4.47%
1M
-21.96%
YTD
-19.33%
6M
-24.24%
1Y
-31.47%
3Y*
100.52%
5Y*
13.84%
10Y*
4.15%
*Multi-year figures are annualized to reflect compound growth (CAGR)

EAT vs. SMMT - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
EAT
Brinker International, Inc.
1.83%8.49%206.37%35.32%-12.79%-35.32%36.16%-0.92%17.27%-18.44%
SMMT
Summit Therapeutics Inc.
-19.33%-1.99%583.72%-38.59%57.99%-42.77%193.75%39.13%-89.62%29.44%

Correlation

The correlation between EAT and SMMT is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.08

Correlation (3Y)
Calculated over the trailing 3-year period

0.13

Correlation (5Y)
Calculated over the trailing 5-year period

0.17

Correlation (10Y)
Calculated over the trailing 10-year period

0.13

Correlation (All Time)
Calculated using the full available price history since Mar 5, 2015

0.12

Fundamentals

Market Cap

EAT:

$6.50B

SMMT:

$10.94B

EPS

EAT:

$10.14

SMMT:

-$1.60

PB Ratio

EAT:

16.02

SMMT:

20.04

Total Revenue (TTM)

EAT:

$5.73B

SMMT:

$0.00

Gross Profit (TTM)

EAT:

$3.45B

SMMT:

-$83.36K

EBITDA (TTM)

EAT:

$807.20M

SMMT:

-$738.34M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

EAT vs. SMMT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

EAT
EAT Risk / Return Rank: 2929
Overall Rank
EAT Sharpe Ratio Rank: 2828
Sharpe Ratio Rank
EAT Sortino Ratio Rank: 2727
Sortino Ratio Rank
EAT Omega Ratio Rank: 2828
Omega Ratio Rank
EAT Calmar Ratio Rank: 3131
Calmar Ratio Rank
EAT Martin Ratio Rank: 2929
Martin Ratio Rank

SMMT
SMMT Risk / Return Rank: 2525
Overall Rank
SMMT Sharpe Ratio Rank: 2424
Sharpe Ratio Rank
SMMT Sortino Ratio Rank: 2828
Sortino Ratio Rank
SMMT Omega Ratio Rank: 2828
Omega Ratio Rank
SMMT Calmar Ratio Rank: 2121
Calmar Ratio Rank
SMMT Martin Ratio Rank: 2424
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

EAT vs. SMMT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Brinker International, Inc. (EAT) and Summit Therapeutics Inc. (SMMT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


EATSMMTDifference
Sharpe ratioReturn per unit of total volatility

+0.10

Sortino ratioReturn per unit of downside risk

-0.03

Omega ratioGain probability vs. loss probability

0.98

0.98

0.00

Calmar ratioReturn relative to maximum drawdown

-0.34

-0.60

+0.26

Martin ratioReturn relative to average drawdown

-0.69

-0.92

+0.23

EAT vs. SMMT - Sharpe Ratio Comparison

The current EAT Sharpe Ratio is -0.32, which is comparable to the SMMT Sharpe Ratio of -0.42. The chart below compares the historical Sharpe Ratios of EAT and SMMT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


EATSMMTDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.32

-0.42

+0.10

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.37

0.08

+0.30

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.25

0.03

+0.22

Sharpe Ratio (All Time)

Calculated using the full available price history

0.28

0.02

+0.26

Drawdowns

EAT vs. SMMT - Drawdown Comparison

The maximum EAT drawdown since its inception was -88.40%, smaller than the maximum SMMT drawdown of -95.75%. Use the drawdown chart below to compare losses from any high point for EAT and SMMT.


Loading charts...

Drawdown Indicators


EATSMMTDifference

Max Drawdown

Largest peak-to-trough decline

-88.40%

-95.75%

+7.35%

Max Drawdown (1Y)

Largest decline over 1 year

-44.41%

-52.76%

+8.35%

Max Drawdown (3Y)

Largest decline over 3 years

-45.92%

-62.26%

+16.34%

Max Drawdown (5Y)

Largest decline over 5 years

-65.54%

-91.78%

+26.24%

Max Drawdown (10Y)

Largest decline over 10 years

-84.94%

-95.75%

+10.81%

Current Drawdown

Current decline from peak

-22.73%

-61.55%

+38.82%

Average Drawdown

Average peak-to-trough decline

-24.34%

-57.64%

+33.30%

Ulcer Index

Depth and duration of drawdowns from previous peaks

21.68%

34.32%

-12.64%

Volatility

EAT vs. SMMT - Volatility Comparison

The current volatility for Brinker International, Inc. (EAT) is 16.59%, while Summit Therapeutics Inc. (SMMT) has a volatility of 22.47%. This indicates that EAT experiences smaller price fluctuations and is considered to be less risky than SMMT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


EATSMMTDifference

Volatility (1M)

Calculated over the trailing 1-month period

16.59%

22.47%

-5.88%

Volatility (6M)

Calculated over the trailing 6-month period

35.50%

56.53%

-21.03%

Volatility (1Y)

Calculated over the trailing 1-year period

46.55%

75.95%

-29.40%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

48.95%

185.12%

-136.17%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

55.09%

144.63%

-89.54%

Dividends

EAT vs. SMMT - Dividend Comparison

Neither EAT nor SMMT has paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
EAT
Brinker International, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.67%3.62%3.46%3.71%2.67%2.50%
SMMT
Summit Therapeutics Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

EAT vs. SMMT - Financials Comparison

This section allows you to compare key financial metrics between Brinker International, Inc. and Summit Therapeutics Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.00500.00M1.00B1.50B20222023202420252026
1.47B
0
(EAT) Total Revenue
(SMMT) Total Revenue
Values in USD except per share items

Frequently Asked Questions


EAT and SMMT have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

SMMT has higher volatility (22.47%) compared to EAT (16.59%). In terms of maximum drawdown, EAT dropped -88.40% vs SMMT's -95.75%.

EAT currently has the higher Sharpe Ratio (-0.32 vs -0.42), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for EAT and SMMT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer